TXG
TXG
NASDAQ · Life Sciences Tools & Services

10X Genomics Inc-Class A

Mid-Cap Stocks Healthcare Stocks
$22.43
+0.38 (+1.72%)
As of May 9, 1:28 AM ET ·
Analyst Consensus
Hold
22
Analysts
High
Coverage
Buy 8 36%
Hold 14 64%
Sell 0 0%
Price Target
Analyst Price Target +106.8% upside
Low Target $30.79
Average Target $46.39
High Target $59.80
Current Price $22.43
Current
$22.43
Target
$46.39
$30.79 $46.39 avg $59.80
Scenario Analysis
Bear Case
$30.79
37.3%
Low target
Base Case
$46.39
+106.8%
Avg target
Bull Case
$59.80
+166.6%
High target
Risk/Reward
4.5x
Highly favorable
Price in Context
52-Week High
$26.45
-15.2% from high
52-Week Low
$7.72
+190.5% from low
50-Day SMA
$18.75
+19.6% vs SMA
200-Day SMA
$14.19
+58.1% vs SMA
RSI (14)
40.8
Neutral
Target vs 52W High
$46.39
+75.4% vs high
Peer Consensus — Life Sciences Tools & Services
Stock Consensus Analysts Buy % Target Upside
TMO
Thermo Fisher Scientific Inc
 Strong Buy 35 89% $369.21 -20.6%
DHR
Danaher Corp
 Strong Buy 30 87% $158.11 -7.6%
WAT
Waters Corp
 Buy 28 57% $189.60 -46.6%
A
Agilent Technologies Inc
 Strong Buy 28 79% $64.69 -44.0%
IQV
Iqvia Holdings Inc
 Strong Buy 31 87% $82.96 -53.6%
MTD
Mettler-Toledo International
 Hold 21 43% $170.43 -84.8%
WST
West Pharmaceutical Services
 Strong Buy 23 78% $136.24 -58.2%
ILMN
Illumina Inc
 Hold 28 54% $169.36 +19.4%